{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:36:07Z","timestamp":1768592167533,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T00:00:00Z","timestamp":1499472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Swiss Foundation for Alcohol Research (SSA FSRA)","award":["242"],"award-info":[{"award-number":["242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00109-017-1556-y","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T17:08:42Z","timestamp":1499533722000},"page":"1077-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["4-O\u2032-methylhonokiol protects from alcohol\/carbon tetrachloride-induced liver injury in mice"],"prefix":"10.1007","volume":"95","author":[{"given":"Eleonora","family":"Patsenker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chicca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheida","family":"Moghadamrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"de Gottardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Hampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Gertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Semmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,8]]},"reference":[{"key":"1556_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","volume":"59","author":"J Rehm","year":"2013","unstructured":"Rehm J, Samokhvalov AV, Shield KD (2013) Global burden of alcoholic liver diseases. J Hepatol 59:160\u2013168","journal-title":"J Hepatol"},{"key":"1556_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","volume":"10","author":"P Burra","year":"2010","unstructured":"Burra P, Senzolo M, Adam R, Delvart V, Karam V, Germani G, Neuberger J, Elita CELT (2010) Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European liver transplant registry). Am J Transplant 10:138\u2013148","journal-title":"Am J Transplant"},{"key":"1556_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","volume":"65","author":"G Addolorato","year":"2016","unstructured":"Addolorato G, Mirijello A, Barrio P, Gual A (2016) Treatment of alcohol use disorders in patients with alcoholic liver disease. J Hepatol 65:618\u2013630","journal-title":"J Hepatol"},{"key":"1556_CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","volume":"53","author":"J Tam","year":"2011","unstructured":"Tam J, Liu J, Mukhopadhyay B, Cinar R, Godlewski G, Kunos G (2011) Endocannabinoids in liver disease. Hepatology 53:346\u2013355","journal-title":"Hepatology"},{"key":"1556_CR5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2013.03.032","volume":"59","author":"A Mallat","year":"2013","unstructured":"Mallat A, Teixeira-Clerc F, Lotersztajn S (2013) Cannabinoid signaling and liver therapeutics. J Hepatol 59:891\u2013896","journal-title":"J Hepatol"},{"key":"1556_CR6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.12673","volume":"39","author":"PP Basu","year":"2014","unstructured":"Basu PP, Aloysius MM, Shah NJ, Brown RS Jr (2014) Review article: the endocannabinoid system in liver disease, a potential therapeutic target. Aliment Pharmacol Ther 39:790\u2013801","journal-title":"Aliment Pharmacol Ther"},{"key":"1556_CR7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2119\/molmed.2011.00149","volume":"17","author":"E Patsenker","year":"2011","unstructured":"Patsenker E, Stoll M, Millonig G, Agaimy A, Wissniowski T, Schneider V, Mueller S, Brenneisen R, Seitz HK, Ocker M et al (2011) Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Mol Med 17:1285\u20131294","journal-title":"Mol Med"},{"key":"1556_CR8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","volume":"31","author":"J Trebicka","year":"2011","unstructured":"Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S et al (2011) Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int 31:860\u2013870","journal-title":"Liver Int"},{"key":"1556_CR9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000324283","volume":"28","author":"SV Siegmund","year":"2010","unstructured":"Siegmund SV (2010) Role of the endocannabinoid system in alcoholic liver disease. Dig Dis 28:751\u2013755","journal-title":"Dig Dis"},{"key":"1556_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24524","volume":"54","author":"A Louvet","year":"2011","unstructured":"Louvet A, Teixeira-Clerc F, Chobert MN, Deveaux V, Pavoine C, Zimmer A, Pecker F, Mallat A, Lotersztajn S (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 54:1217\u20131226","journal-title":"Hepatology"},{"key":"1556_CR11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.23779","volume":"52","author":"F Teixeira-Clerc","year":"2010","unstructured":"Teixeira-Clerc F, Belot MP, Manin S, Deveaux V, Cadoudal T, Chobert MN, Louvet A, Zimmer A, Tordjmann T, Mallat A et al (2010) Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 52:1046\u20131059","journal-title":"Hepatology"},{"key":"1556_CR12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1189\/jlb.0307180","volume":"82","author":"M Rajesh","year":"2007","unstructured":"Rajesh M, Pan H, Mukhopadhyay P, Batkai S, Osei-Hyiaman D, Hasko G, Liaudet L, Gao B, Pacher P (2007) Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia\/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol 82:1382\u20131389","journal-title":"J Leukoc Biol"},{"key":"1556_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-9-35","volume":"9","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Choi DY, Choi IS, Kim KH, Kim YH, Kim HM, Lee K, Cho WG, Jung JK, Han SB et al (2012) Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models. J Neuroinflammation 9:35","journal-title":"J Neuroinflammation"},{"key":"1556_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","volume":"130","author":"YJ Lee","year":"2011","unstructured":"Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT (2011) Therapeutic applications of compounds in the Magnolia Family. Pharmacol Ther 130:157\u2013176","journal-title":"Pharmacol Ther"},{"key":"1556_CR15","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/ptr.4643","volume":"26","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Choi DY, Han SB, Kim YH, Kim KH, Hwang BY, Kang JK, Lee BJ, Oh KW, Hong JT (2012) Inhibitory effect of ethanol extract of Magnolia Officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease via regulating beta-secretase activity. Phytother Res 26:1884\u20131892","journal-title":"Phytother Res"},{"key":"1556_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.03.072","volume":"116","author":"S Bertini","year":"2016","unstructured":"Bertini S, Chicca A, Arena C, Chicca S, Saccomanni G, Gertsch J, Manera C, Macchia M (2016) Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands. Eur J Med Chem 116:252\u2013266","journal-title":"Eur J Med Chem"},{"key":"1556_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-015-0307-7","volume":"12","author":"A Chicca","year":"2015","unstructured":"Chicca A, Gachet MS, Petrucci V, Schuehly W, Charles RP, Gertsch J (2015) 4\u2032-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation. J Neuroinflammation 12:89","journal-title":"J Neuroinflammation"},{"key":"1556_CR18","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/mnfr.201300113","volume":"57","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Choi MS, Cha BY, Woo JT, Park YB, Kim SR, Jung UJ (2013) Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. Mol Nutr Food Res 57:1988\u20131998","journal-title":"Mol Nutr Food Res"},{"key":"1556_CR19","first-page":"965954","volume":"2014","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Chen J, Jiang X, Wang J, Yan X, Zheng Y, Conklin DJ, Kim KS, Kim KH, Tan Y et al (2014) The magnolia bioactive constituent 4-O-methylhonokiol protects against high-fat diet-induced obesity and systemic insulin resistance in mice. Oxid Med Cell Longev 2014:965954","journal-title":"Oxid Med Cell Longev"},{"key":"1556_CR20","first-page":"476","volume":"49","author":"JJ Wang","year":"2014","unstructured":"Wang JJ, Zhao R, Liang JC, Chen Y (2014) The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by high-fat diet and streptozotocin. Yao Xue Xue Bao 49:476\u2013481","journal-title":"Yao Xue Xue Bao"},{"key":"1556_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.lfs.2006.09.037","volume":"80","author":"EJ Sohn","year":"2007","unstructured":"Sohn EJ, Kim CS, Kim YS, Jung DH, Jang DS, Lee YM, Kim JS (2007) Effects of magnolol (5,5\u2032-diallyl-2,2\u2032-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci 80:468\u2013475","journal-title":"Life Sci"},{"key":"1556_CR22","first-page":"6327","volume":"9","author":"J Sun","year":"2015","unstructured":"Sun J, Fu X, Liu Y, Wang Y, Huo B, Guo Y, Gao X, Li W, Hu X (2015) Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice. Drug Des Devel Ther 9:6327\u20136342","journal-title":"Drug Des Devel Ther"},{"key":"1556_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-2005-837757","volume":"71","author":"EJ Park","year":"2005","unstructured":"Park EJ, Zhao YZ, Kim YH, Lee BH, Sohn DH (2005) Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro. Planta Med 71:82\u201384","journal-title":"Planta Med"},{"key":"1556_CR24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/1535370214547123","volume":"240","author":"JH Lee","year":"2015","unstructured":"Lee JH, Jung JY, Jang EJ, Jegal KH, Moon SY, Ku SK, Kang SH, Cho IJ, Park SJ, Lee JR et al (2015) Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway. Exp Biol Med (Maywood) 240:508\u2013518","journal-title":"Exp Biol Med (Maywood)"},{"key":"1556_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jep.2014.09.031","volume":"157","author":"MS Seo","year":"2014","unstructured":"Seo MS, Hong SW, Yeon SH, Kim YM, Um KA, Kim JH, Kim HJ, Chang KC, Park SW (2014) Magnolia Officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes. J Ethnopharmacol 157:140\u2013148","journal-title":"J Ethnopharmacol"},{"key":"1556_CR26","first-page":"674690","volume":"2014","author":"J Wang","year":"2014","unstructured":"Wang J, Zhang C, Zhang Z, Chen Q, Lu X, Shao M, Chen L, Yang H, Zhang F, Cheng P et al (2014) BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress. Oxid Med Cell Longev 2014:674690","journal-title":"Oxid Med Cell Longev"},{"key":"1556_CR27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1254\/jphs.08182FP","volume":"109","author":"HQ Yin","year":"2009","unstructured":"Yin HQ, Je YT, Kim YC, Shin YK, Sung S, Lee K, Jeong GS, Kim YC, Lee BH (2009) Magnolia Officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. J Pharmacol Sci 109:486\u2013495","journal-title":"J Pharmacol Sci"},{"key":"1556_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3177\/jnsv.63.35","volume":"63","author":"XY Han","year":"2017","unstructured":"Han XY, Hu JN, Wang Z, Wei SN, Zheng SW, Wang YP, Li W (2017) 5-HMF attenuates liver fibrosis in CCl4-plus-alcohol-induced mice by suppression of oxidative stress. J Nutr Sci Vitaminol (Tokyo) 63:35\u201343","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"1556_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola A, Mathews S, Ki SH, Wang H, Gao B (2013) Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 8:627\u2013637","journal-title":"Nat Protoc"},{"key":"1556_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1159\/000324280","volume":"28","author":"GE Arteel","year":"2010","unstructured":"Arteel GE (2010) Animal models of alcoholic liver disease. Dig Dis 28:729\u2013736","journal-title":"Dig Dis"},{"key":"1556_CR31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mrd.22489","volume":"82","author":"J Schindelin","year":"2015","unstructured":"Schindelin J, Rueden CT, Hiner MC, Eliceiri KW (2015) The ImageJ ecosystem: an open platform for biomedical image analysis. Mol Reprod Dev 82:518\u2013529","journal-title":"Mol Reprod Dev"},{"key":"1556_CR32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2012-111835","volume":"29","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Choi DY, Lee YK, Lee YM, Han SB, Kim YH, Kim KH, Nam SY, Lee BJ, Kang JK et al (2012) 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of beta-secretase activity. J Alzheimers Dis 29:677\u2013690","journal-title":"J Alzheimers Dis"},{"key":"1556_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110545","volume":"27","author":"IS Choi","year":"2011","unstructured":"Choi IS, Lee YJ, Choi DY, Lee YK, Lee YH, Kim KH, Kim YH, Jeon YH, Kim EH, Han SB et al (2011) 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-beta generation and accumulation in a mouse model of Alzheimer's disease. J Alzheimers Dis 27:127\u2013141","journal-title":"J Alzheimers Dis"},{"key":"1556_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1742-2094-9-135","volume":"9","author":"J Gertsch","year":"2012","unstructured":"Gertsch J, Anavi-Goffer S (2012) Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? J Neuroinflammation 9:135","journal-title":"J Neuroinflammation"},{"key":"1556_CR35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biocel.2015.05.007","volume":"64","author":"JH Cho","year":"2015","unstructured":"Cho JH, Lee RH, Jeon YJ, Shin JC, Park SM, Choi NJ, Seo KS, Yoon G, Cho SS, Kim KH et al (2015) Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft. Int J Biochem Cell Biol 64:287\u2013297","journal-title":"Int J Biochem Cell Biol"},{"key":"1556_CR36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1476-5381.2012.02235.x","volume":"168","author":"NJ Lee","year":"2013","unstructured":"Lee NJ, Oh JH, Ban JO, Shim JH, Lee HP, Jung JK, Ahn BW, Yoon DY, Han SB, Ham YW et al (2013) 4-O-methylhonokiol, a PPARgamma agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-kappaB activity. Br J Pharmacol 168:1133\u20131145","journal-title":"Br J Pharmacol"},{"key":"1556_CR37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jnutbio.2011.03.013","volume":"23","author":"JH Oh","year":"2012","unstructured":"Oh JH, Ban JO, Cho MC, Jo M, Jung JK, Ahn B, Yoon DY, Han SB, Hong JT (2012) 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-kappaB activity. J Nutr Biochem 23:706\u2013715","journal-title":"J Nutr Biochem"},{"key":"1556_CR38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.chembiol.2011.05.012","volume":"18","author":"W Schuehly","year":"2011","unstructured":"Schuehly W, Paredes JM, Kleyer J, Huefner A, Anavi-Goffer S, Raduner S, Altmann KH, Gertsch J (2011) Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists. Chem Biol 18:1053\u20131064","journal-title":"Chem Biol"},{"key":"1556_CR39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann S, Graf J, Roderfeld M, Roeb E (2007) Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46:955\u2013975","journal-title":"J Hepatol"},{"key":"1556_CR40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","volume":"163","author":"A Mallat","year":"2011","unstructured":"Mallat A, Teixeira-Clerc F, Deveaux V, Manin S, Lotersztajn S (2011) The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings. Br J Pharmacol 163:1432\u20131440","journal-title":"Br J Pharmacol"},{"key":"1556_CR41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 50:193\u2013211","journal-title":"Prog Lipid Res"},{"key":"1556_CR42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12272-014-0456-8","volume":"38","author":"HS Kim","year":"2015","unstructured":"Kim HS, Ryu HS, Kim JS, Kim YG, Lee HK, Jung JK, Kwak YS, Lee K, Seo SY, Yun J et al (2015) Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models. Arch Pharm Res 38:813\u2013825","journal-title":"Arch Pharm Res"},{"key":"1556_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20011470","volume":"196","author":"N Cusson","year":"2002","unstructured":"Cusson N, Oikemus S, Kilpatrick ED, Cunningham L, Kelliher M (2002) The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death. J Exp Med 196:15\u201326","journal-title":"J Exp Med"},{"key":"1556_CR44","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1073\/pnas.1409389111","volume":"111","author":"JE Roderick","year":"2014","unstructured":"Roderick JE, Hermance N, Zelic M, Simmons MJ, Polykratis A, Pasparakis M, Kelliher MA (2014) Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis. Proc Natl Acad Sci U S A 111:14436\u201314441","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1556_CR45","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H et al (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157:1175\u20131188","journal-title":"Cell"},{"key":"1556_CR46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/bdrb.21092","volume":"101","author":"C Lin","year":"2014","unstructured":"Lin C, Yon JM, Hong JT, Lee JK, Jeong J, Baek IJ, Lee BJ, Yun YW, Nam SY (2014) 4-O-methylhonokiol inhibits serious embryo anomalies caused by nicotine via modulations of oxidative stress, apoptosis, and inflammation. Birth Defects Res B Dev Reprod Toxicol 101:125\u2013134","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"1556_CR47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jnutbio.2010.04.002","volume":"22","author":"YK Lee","year":"2011","unstructured":"Lee YK, Choi IS, Ban JO, Lee HJ, Lee US, Han SB, Jung JK, Kim YH, Kim KH, Oh KW et al (2011) 4-O-methylhonokiol attenuated beta-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J Nutr Biochem 22:476\u2013486","journal-title":"J Nutr Biochem"},{"key":"1556_CR48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4014\/jmb.1411.11073","volume":"25","author":"S Hyun","year":"2015","unstructured":"Hyun S, Kim MS, Song YS, Bak Y, Ham SY, Lee DH, Hong J, Yoon do Y (2015) Peroxisome proliferator-activated receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by triggering the intrinsic apoptosis pathway and inhibiting the PI3K\/Akt survival pathway in SiHa human cervical cancer cells. J Microbiol Biotechnol 25:334\u2013342","journal-title":"J Microbiol Biotechnol"},{"key":"1556_CR49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2016.01.011","volume":"773","author":"EA Abd El-Haleim","year":"2016","unstructured":"Abd El-Haleim EA, Bahgat AK, Saleh S (2016) Effects of combined PPAR-gamma and PPAR-alpha agonist therapy on fructose induced NASH in rats: modulation of gene expression. Eur J Pharmacol 773:59\u201370","journal-title":"Eur J Pharmacol"},{"key":"1556_CR50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ptr.5033","volume":"28","author":"HE Yu","year":"2014","unstructured":"Yu HE, Oh SJ, Ryu JK, Kang JS, Hong JT, Jung JK, Han SB, Seo SY, Kim YH, Park SK et al (2014) Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats. Phytother Res 28:568\u2013578","journal-title":"Phytother Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-017-1556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-017-1556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T16:51:30Z","timestamp":1659199890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-017-1556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,8]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1556"],"URL":"https:\/\/doi.org\/10.1007\/s00109-017-1556-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,8]]}}}